Your browser doesn't support javascript.
loading
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma.
Raggi, Chiara; Fiaccadori, Karim; Pastore, Mirella; Correnti, Margherita; Piombanti, Benedetta; Forti, Elisa; Navari, Nadia; Abbadessa, Giovanni; Hall, Terence; Destro, Annarita; Di Tommaso, Luca; Roncalli, Massimo; Meng, Fanyin; Glaser, Shannon; Rovida, Elisabetta; Peraldo-Neia, Caterina; Olaizola, Paula; Banales, Jesus M; Gerussi, Alessio; Elvevi, Alessandra; Droz Dit Busset, Michele; Bhoori, Sherrie; Mazzaferro, Vincenzo; Alpini, Gianfranco; Marra, Fabio; Invernizzi, Pietro.
Afiliação
  • Raggi C; Humanitas Clinical and Research Center, Rozzano, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: chiara.raggi@unifi.it.
  • Fiaccadori K; Humanitas Clinical and Research Center, Rozzano, Italy.
  • Pastore M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Correnti M; Humanitas Clinical and Research Center, Rozzano, Italy.
  • Piombanti B; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Forti E; Humanitas Clinical and Research Center, Rozzano, Italy.
  • Navari N; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Abbadessa G; Clinical Development Department, ArQule, Inc., Burlington, Massachusetts.
  • Hall T; Clinical Development Department, ArQule, Inc., Burlington, Massachusetts.
  • Destro A; Pathology Unit, Humanitas Research Hospital, Rozzano, Italy.
  • Di Tommaso L; Pathology Unit, Humanitas Research Hospital, Rozzano, Italy; University of Milan Medical School, Milan, Italy.
  • Roncalli M; Pathology Unit, Humanitas Research Hospital, Rozzano, Italy; University of Milan Medical School, Milan, Italy.
  • Meng F; Department of Research, Central Texas Veterans Health Care System, Baylor Scott & White Digestive Disease Research Center, Scott & White Health, Department of Medical Physiology, Texas A&M University, College of Medicine, Temple, Texas.
  • Glaser S; Department of Research, Central Texas Veterans Health Care System, Baylor Scott & White Digestive Disease Research Center, Scott & White Health, Department of Medical Physiology, Texas A&M University, College of Medicine, Temple, Texas.
  • Rovida E; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
  • Peraldo-Neia C; Cancer Genomics Laboratory, Fondazione Edo and Elvo Tempia, Biella, Italy.
  • Olaizola P; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (Universidad del País Vasco/Euskal Herriko Unibertsitatea), Networked Biomedical Research Center for Hepatic and Digestive Diseases, Ikerbasque, San Sebas
  • Banales JM; Department of Liver and Gastrointestinal Diseases, Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (Universidad del País Vasco/Euskal Herriko Unibertsitatea), Networked Biomedical Research Center for Hepatic and Digestive Diseases, Ikerbasque, San Sebas
  • Gerussi A; Division of Gastroenterology and Center for Autoimmune Liver Diseases, San Gerardo Hospital, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
  • Elvevi A; Division of Gastroenterology and Center for Autoimmune Liver Diseases, San Gerardo Hospital, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
  • Droz Dit Busset M; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Bhoori S; Gastroenterology and Liver Transplant Hepatology, IRCCS Foundation National Cancer Institute, Milan, Italy.
  • Mazzaferro V; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, IRCCS Foundation National Cancer Institute, Milan, Italy; Department of Surgery, University of Milan, Milan, Italy.
  • Alpini G; Department of Research, Central Texas Veterans Health Care System, Baylor Scott & White Digestive Disease Research Center, Scott & White Health, Department of Medical Physiology, Texas A&M University, College of Medicine, Temple, Texas.
  • Marra F; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Invernizzi P; Humanitas Clinical and Research Center, Rozzano, Italy; Division of Gastroenterology and Center for Autoimmune Liver Diseases, San Gerardo Hospital, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy. Electronic address: pietro.invernizzi@unimib.it.
Am J Pathol ; 189(10): 2090-2101, 2019 10.
Article em En | MEDLINE | ID: mdl-31351075
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Inibidores de Proteínas Quinases / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Transição Epitelial-Mesenquimal / Compostos de Anilina Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias dos Ductos Biliares / Colangiocarcinoma / Inibidores de Proteínas Quinases / Receptor Tipo 2 de Fator de Crescimento de Fibroblastos / Transição Epitelial-Mesenquimal / Compostos de Anilina Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article